Occurrence of Temporomandibular Disorders among patients undergoing treatment for Obstructive Sleep Apnoea Syndrome (OSAS) using Mandibular Advancement Device (MAD): A Systematic Review conducted according to PRISMA guidelines and the Cochrane handbook for systematic reviews of interventions.

MAD Sleep Disorders TMD bruxism mandibular advancement device mandibular protrusion obstructive sleep apnoea syndrome oral appliance osteoarthralgia temporomandibular disorders

Journal

Journal of oral rehabilitation
ISSN: 1365-2842
Titre abrégé: J Oral Rehabil
Pays: England
ID NLM: 0433604

Informations de publication

Date de publication:
Dec 2023
Historique:
revised: 01 08 2023
received: 26 06 2023
accepted: 08 08 2023
medline: 3 11 2023
pubmed: 30 8 2023
entrez: 30 8 2023
Statut: ppublish

Résumé

Patients undergoing mandibular advancement device (MAD) therapy for obstructive sleep apnea (OSA) may experience changes in jaw position and altered occlusion. This could potentially contribute to the development or exacerbation of TMD symptoms. The literature on the long-term impact of MAD treated for OSA on TMD is scarce. Hence, this review was undertaken to ascertain the occurrence of TMD in MAD users. A comprehensive search protocol was implemented across several online databases using MeSH keywords and Boolean operators. A standardised data extraction form was developed specifically for this review. Two reviewers independently extracted the data. RoB-2 was used to evaluate the methodological quality of the included studies. A total of 13 clinical studies were selected for this review. Some studies reported a significant reduction in the severity and frequency of TMD symptoms following MAD treatment. However, other studies did not observe significant changes in TMD symptoms or TMJ-related parameters from baseline to follow-up intervals. Temporary increases in TMJ-related pain or symptoms at the beginning of the follow-up period, which later subsided, were reported in some studies. Overall, MAD was not discontinued in any OSA patient due to TMDs. The findings reveal that different outcomes associated with TMD are affected differently by MAD treatment for OSAS. According to a few studies, MAD therapy significantly reduced the severity and frequency of TMD symptoms. Other research, however, found no appreciable modifications in TMD symptoms or TMJ-related indicators. Although the overall results point to no significant effect of MAD treatment on TMD symptoms, the disparity in results between studies highlights the need for additional studies using standardised approaches.

Sections du résumé

BACKGROUND BACKGROUND
Patients undergoing mandibular advancement device (MAD) therapy for obstructive sleep apnea (OSA) may experience changes in jaw position and altered occlusion. This could potentially contribute to the development or exacerbation of TMD symptoms. The literature on the long-term impact of MAD treated for OSA on TMD is scarce. Hence, this review was undertaken to ascertain the occurrence of TMD in MAD users.
METHODS METHODS
A comprehensive search protocol was implemented across several online databases using MeSH keywords and Boolean operators. A standardised data extraction form was developed specifically for this review. Two reviewers independently extracted the data. RoB-2 was used to evaluate the methodological quality of the included studies.
RESULTS RESULTS
A total of 13 clinical studies were selected for this review. Some studies reported a significant reduction in the severity and frequency of TMD symptoms following MAD treatment. However, other studies did not observe significant changes in TMD symptoms or TMJ-related parameters from baseline to follow-up intervals. Temporary increases in TMJ-related pain or symptoms at the beginning of the follow-up period, which later subsided, were reported in some studies. Overall, MAD was not discontinued in any OSA patient due to TMDs.
CONCLUSION CONCLUSIONS
The findings reveal that different outcomes associated with TMD are affected differently by MAD treatment for OSAS. According to a few studies, MAD therapy significantly reduced the severity and frequency of TMD symptoms. Other research, however, found no appreciable modifications in TMD symptoms or TMJ-related indicators. Although the overall results point to no significant effect of MAD treatment on TMD symptoms, the disparity in results between studies highlights the need for additional studies using standardised approaches.

Identifiants

pubmed: 37644889
doi: 10.1111/joor.13574
doi:

Types de publication

Systematic Review Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1554-1563

Informations de copyright

© 2023 The Authors. Journal of Oral Rehabilitation published by John Wiley & Sons Ltd.

Références

Senaratna CV, Perret JL, Lodge CJ, et al. Prevalence of obstructive sleep apnea in the general population: a systematic review. Sleep Med Rev. 2017;34:70-81.
Heinzer R, Vat S, Marques-Vidal P, et al. Prevalence of sleep-disordered breathing in the general population: the HypnoLaus study. Lancet Respir Med. 2015;3:310-318.
Yaggi HK, Strohl KP. Adult obstructive sleep apnea/hypopnea syndrome: definitions, risk factors, and pathogenesis. Clin Chest Med. 2010;31:179-186.
Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. The report of an American Academy of sleep medicine task force. Sleep. 1999;22:667-689.
Young T, Finn L, Peppard PE, et al. Sleep disordered breathing and mortality: eighteen-year follow-up of the Wisconsin sleep cohort. Sleep. 2008;31:1071-1078.
Nieto FJ, Young TB, Lind BK, et al. Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. Sleep Heart Health Study JAMA. 2000;283:1829-1836.
Kulkas A, Tiihonen P, Eskola K, Julkunen P, Mervaala E, Töyräs J. Novel parameters for evaluating severity of sleep disordered breathing and for supporting diagnosis of sleep apnea-hypopnea syndrome. J Med Eng Technol. 2013;37:135-143.
Almeida FR, Bansback N. Long-term effectiveness of oral appliance versus CPAP therapy and the emerging importance of understanding patient preferences. Sleep. 2013;36:1271-1272.
Kushida CA, Morgenthaler TI, Littner MR, et al. Practice parameters for the treatment of snoring and obstructive sleep apnea with Oral appliances: an update for 2005. Sleep. 2006;29:240-243.
Schwartz M, Acosta L, Hung Y-L, Padilla M, Enciso R. Effects of CPAP and mandibular advancement device treatment in obstructive sleep apnea patients: a systematic review and meta-analysis. Sleep and Breathing. 2018;22:555-568.
Sutherland K, Kairaitis K, Yee BJ, Cistulli PA. From CPAP to tailored therapy for obstructive sleep apnoea. Multidiscip Respir Med. 2018;13:44.
Barnes M, McEvoy RD, Banks S, et al. Efficacy of positive airway pressure and Oral appliance in mild to moderate obstructive sleep apnea. Am J Respir Crit Care Med. 2004;170:656-664.
Bortolotti F, Corazza G, Bartolucci ML, Incerti Parenti S, Paganelli C, Alessandri-Bonetti G. Dropout and adherence of obstructive sleep apnoea patients to mandibular advancement device therapy: a systematic review of randomised controlled trials with meta-analysis and meta-regression. J Oral Rehabil. 2022;49:553-572.
Bartolucci ML, Bortolotti F, Corazza G, Incerti Parenti S, Paganelli C, Alessandri Bonetti G. Effectiveness of different mandibular advancement device designs in obstructive sleep apnoea therapy: a systematic review of randomised controlled trials with meta-analysis. J Oral Rehabil. 2021;48:469-486.
Alessandri-Bonetti A, Bortolotti F, Moreno-Hay I, et al. Effects of mandibular advancement device for obstructive sleep apnea on temporomandibular disorders: a systematic review and meta-analysis. Sleep Med Rev. 2019;48:101211.
Ahmed N, Humayun M, Abbasi M, Jamayet N, Habib S, Zafar M. Comparison of canine-guided occlusion with other occlusal schemes in removable complete dentures: a systematic review. Prosthesis. 2021;3:85-98.
Pugliese A, Cataneo E, Fortunato L. Construction of a removable partial denture (RPD): comparison between the analog procedure and the selective laser melting procedure. Prosthesis. 2021;3:428-436.
Villias A, Karkazis H, Yannikakis S, Artopoulou I, Polyzois G. Is the number of appointments for complete denture fabrication reduced with CAD-CAM? A literature review. Prosthesis. 2022;4:91-101.
D'Addazio G, Xhajanka E, Cerone P, et al. Traditional removable partial dentures versus implant-supported removable partial dentures: a retrospective, observational Oral health-related quality-of-life study. Prosthesis. 2021;3:361-369.
Minervini G, Franco R, Marrapodi MM, Fiorillo L, Cervino G, Cicciù M. Prevalence of temporomandibular disorders (TMD) in pregnancy: a systematic review with meta-analysis. J Oral Rehabil. 2023;50:627-634. doi:10.1111/joor.13458
Inchingolo F, Tatullo M, Abenavoli FM, et al. Non-syndromic multiple supernumerary teeth in a family unit with a normal karyotype: case report. Int J Med Sci. 2010;7(6):378-384. doi:10.7150/ijms.7.378
Inchingolo F, Ballini A, Cagiano R, et al. Immediately loaded dental implants bioactivated with platelet-rich plasma (PRP) placed in maxillary and mandibular region. Clin Ter. 2015;166(3):e146-e152.
Minervini G, Franco R, Marrapodi MM, et al. Correlation between temporomandibular disorders (TMD) and posture evaluated trough the diagnostic criteria for temporomandibular disorders (DC/TMD): a systematic review with meta-analysis. J Clin Med. 2023;12(7):2652. doi:10.3390/jcm12072652
Minervini G, Franco R, Marrapodi MM, Fiorillo L, Cervino G, Cicciù M. Economic inequalities and temporomandibular disorders: a systematic review with meta-analysis. J Oral Rehabil. 2023;50:715-723. doi:10.1111/joor.13491
Qamar Z, Alghamdi AMS, Bin HNK, et al. Impact of temporomandibular disorders on oral health-related quality of life: a systematic review and meta-analysis. J Oral Rehabil. 2023;50:706-714. doi:10.1111/joor.13472
Minervini G, Franco R, Marrapodi MM, Ronsivalle V, Shapira I, Cicciù M. Prevalence of temporomandibular disorders in subjects affected by Parkinson disease: a systematic review and metanalysis. J Oral Rehabil. 2023;50:877-885. doi:10.1111/joor.13496
Arya S, Kaji AH, Boermeester MA. PRISMA reporting guidelines for meta-analyses and systematic reviews. JAMA Surg. 2021;156:789.
Sterne JAC, Savović J, Page MJ, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366:l4898.
Bondemark L. Craniomandibular status and function in patients with habitual snoring and obstructive sleep apnoea after nocturnal treatment with a mandibular advancement splint: a 2-year follow-up. European J Orthodont. 2000;22:53-60.
Doff MHJ, Veldhuis SKB, Hoekema A, et al. Long-term oral appliance therapy in obstructive sleep apnea syndrome: a controlled study on temporomandibular side effects. Clin Oral Investig. 2012;16:689-697.
Fransson AMC, Tegelberg Å, Johansson A, Wenneberg B. Influence on the masticatory system in treatment of obstructive sleep apnea and snoring with a mandibular protruding device: a 2-year follow-up. Am J Orthod Dentofacial Orthop. 2004;126:687-693.
Giannasi LC, Almeida FR, Magini M, et al. Systematic assessment of the impact of oral appliance therapy on the temporomandibular joint during treatment of obstructive sleep apnea: long-term evaluation. Sleep Breath. 2009;13:375-381.
Knappe SW, Bakke M, Svanholt P, Petersson A, Sonnesen L. Long-term side effects on the temporomandibular joints and oro-facial function in patients with obstructive sleep apnoea treated with a mandibular advancement device. J Oral Rehabil. 2017;44:354-362.
Martínez-Gomis J, Willaert E, Nogues L, Pascual M, Somoza M, Monasterio C. Five years of sleep apnea treatment with a mandibular advancement device. Angle Orthod. 2010;80:30-36.
Näpänkangas R, Raunio A, Sipilä K, Raustia A. Effect of mandibular advancement device therapy on the signs and symptoms of temporomandibular disorders. J Oral Maxillofac Res. 2012;3:e5. doi:10.5037/jomr.2012.3405
Nikolopoulou M, Aarab G, Ahlberg J, Hamburger HL, Lange J, Lobbezoo F. Oral appliance therapy versus nasal continuous positive airway pressure in obstructive sleep apnea: a randomized, placebo-controlled trial on temporomandibular side-effects. Clin Exp Dent Res. 2020;6:400-406.
Perez CV, de Leeuw R, Okeson JP, et al. The incidence and prevalence of temporomandibular disorders and posterior open bite in patients receiving mandibular advancement device therapy for obstructive sleep apnea. Sleep Breath. 2013;17:323-332.
Ranieri ALP, Jales SMCP, Formigoni GGS, de Alóe FS, Tavares SMA, Siqueira JTT. Treatment of obstructive sleep apnea syndrome in patients from a teaching hospital in Brazil: is it possible? Sleep Breath. 2009;13:121-125.
Tegelberg Å, Walker-Engström M, Vestling O, Wilhelmsson B. Two different degrees of mandibular advancement with a dental appliance in treatment of patients with mild to moderate obstructive sleep apnea. Acta Odontol Scand. 2003;61:356-362.
Walker-Engström M-L, Ringqvist I, Vestling O, Wilhelmsson B, Tegelberg Å. A prospective randomized study comparing two different degrees of mandibular advancement with a dental appliance in treatment of severe obstructive sleep apnea. Sleep Breath. 2003;7:119-130.
Zhou J, Li D, Zhu P, et al. Effect of mandibular advancement device on the stomatognathic system in patients with mild-to-moderate obstructive sleep apnoea-hypopnoea syndrome. J Oral Rehabil. 2020;47:889-901.
de Leeuw R. Orofacial Pain: Guidelines for Assessment. Diagnosis and Management; 2008:4.
Ramar K, Dort LC, Katz SG, et al. Clinical practice guideline for the treatment of obstructive sleep apnea and snoring with Oral appliance therapy: an update for 2015. J Clin Sleep Med. 2015;11:773-827.
Naeije M, te Veldhuis AH, te Veldhuis EC, Visscher CM, Lobbezoo F. Disc displacement within the human temporomandibular joint: a systematic review of a ‘noisy annoyance’. J Oral Rehabil. 2013;40:139-158.
Bush FM, Harkins SW, Harrington WG, Price DD. Analysis of gender effects on pain perception and symptom presentation in temporomandibular pain. Pain. 1993;53:73-80.
Bueno CH, Pereira DD, Pattussi MP, Grossi PK, Grossi ML. Gender differences in temporomandibular disorders in adult populational studies: a systematic review and meta-analysis. J Oral Rehabil. 2018;45:720-729.
Pigozzi LB, Pereira DD, Pattussi MP, et al. Quality of life in young and middle age adult temporomandibular disorders patients and asymptomatic subjects: a systematic review and meta-analysis. Health Qual Life Outcomes. 2021;19:83.
Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S. The occurrence of sleep-disordered breathing among middle-aged adults. New Eng J Med. 1993;328:1230-1235.
Quinzi V, Marchetti E, Guerriero L, Bosco F, Marzo G, Mummolo S. Dentoskeletal class II malocclusion: maxillary molar distalization with no-compliance fixed orthodontic equipment. Dent J (Basel). 2020;8(1):26. doi:10.3390/dj8010026

Auteurs

Akshayraj Langaliya (A)

Department of Conservative Dentistry and Endodontics AMC Dental College and Hospital, Ahmedabad, Gujarat, India.

Mohammad Khursheed Alam (MK)

Orthodontic Division, Preventive Dentistry Department, Orthodontic Division, College of Dentistry, Jouf University, Sakakah, Saudi Arabia.

Usha Hegde (U)

Department of Oral Pathology and Microbiology JSS Dental College & Hospital Mysore JSS Academy of Higher Education & Research, Mysore, India.

Mangesh Shenoy Panakaje (MS)

Department of Oral & Maxillofacial Pathology and Oral Microbiology, Affiliated College, A B Shetty Memorial Institute of Dental Sciences (A Constituent College of Nitte Deemed to be University) Karnataka, Mangalore, India.

Gabriele Cervino (G)

School of Dentistry, Department of Biomedical and Dental Sciences and Morphofunctional Imaging, University of Messina, Messina, Italy.

Giuseppe Minervini (G)

Multidisciplinary Department of Medical-Surgical and Odontostomatological Specialties, University of Campania "Luigi Vanvitelli", Naples, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH